MXPA01013302A - Vacunas para el virus de la parainfluenza (piv) quimerico para humanos-bovinos atenuadas. - Google Patents
Vacunas para el virus de la parainfluenza (piv) quimerico para humanos-bovinos atenuadas.Info
- Publication number
- MXPA01013302A MXPA01013302A MXPA01013302A MXPA01013302A MXPA01013302A MX PA01013302 A MXPA01013302 A MX PA01013302A MX PA01013302 A MXPA01013302 A MX PA01013302A MX PA01013302 A MXPA01013302 A MX PA01013302A MX PA01013302 A MXPA01013302 A MX PA01013302A
- Authority
- MX
- Mexico
- Prior art keywords
- piv
- human
- bovine
- genome
- chimeric
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title abstract 5
- 230000002238 attenuated effect Effects 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 208000002606 Paramyxoviridae Infections Diseases 0.000 title abstract 2
- 101150034575 piv gene Proteins 0.000 abstract 18
- 108090000623 proteins and genes Proteins 0.000 abstract 5
- 241000283690 Bos taurus Species 0.000 abstract 4
- 239000013598 vector Substances 0.000 abstract 2
- 108090000288 Glycoproteins Proteins 0.000 abstract 1
- 241000282412 Homo Species 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 108020001580 protein domains Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14313499P | 1999-07-09 | 1999-07-09 | |
| PCT/US2000/017066 WO2001004320A1 (en) | 1999-07-09 | 2000-06-16 | Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA01013302A true MXPA01013302A (es) | 2004-03-10 |
Family
ID=22502741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA01013302A MXPA01013302A (es) | 1999-07-09 | 2000-06-16 | Vacunas para el virus de la parainfluenza (piv) quimerico para humanos-bovinos atenuadas. |
Country Status (12)
| Country | Link |
|---|---|
| EP (3) | EP2019141A3 (enExample) |
| JP (1) | JP4813711B2 (enExample) |
| KR (1) | KR100940776B1 (enExample) |
| CN (2) | CN101392239A (enExample) |
| AT (1) | ATE408693T1 (enExample) |
| BR (1) | BR0013190A (enExample) |
| CA (1) | CA2378661A1 (enExample) |
| DE (1) | DE60040289D1 (enExample) |
| ES (1) | ES2312347T3 (enExample) |
| IL (2) | IL147167A0 (enExample) |
| MX (1) | MXPA01013302A (enExample) |
| WO (1) | WO2001004320A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7192593B2 (en) | 1997-05-23 | 2007-03-20 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens |
| MXPA01008108A (es) * | 1999-12-10 | 2004-11-12 | Health | Uso de virus de parainfluenza recombinante (pivs) como vectores para la proteccioncontra la infeccion y enfermedad provocadas por piv y otros patogenos humanos. |
| US6764685B1 (en) | 2000-03-21 | 2004-07-20 | Medimmune Vaccines, Inc. | Recombinant parainfluenza virus expression systems and vaccines |
| AU2001271909A1 (en) * | 2000-07-05 | 2002-01-14 | The Government Of The United States Of America, As Represented By The Department Of Health And Human Services | Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines |
| UA93981C2 (ru) | 2001-01-19 | 2011-03-25 | Вироновативе Б.B. | Вирус, который вызывает заболевание дыхательных путей у чувствительных k этому млекопитающих |
| US8715922B2 (en) | 2001-01-19 | 2014-05-06 | ViroNovative | Virus causing respiratory tract illness in susceptible mammals |
| EP1456398B1 (en) | 2001-11-21 | 2011-05-11 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Recovery of recombinant human parainfluenza virus type 1 (hpivi) from cdna |
| CA2477235A1 (en) | 2002-02-21 | 2003-09-04 | Medimmune Vaccines, Inc. | Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| US7820181B2 (en) | 2002-09-18 | 2010-10-26 | The United States Of America As Represented By The Department Of Health And Human Services | Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens |
| JP2007524372A (ja) | 2003-02-28 | 2007-08-30 | ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 組換えヒトメタニューモウイルスおよびその使用 |
| CA2523657A1 (en) * | 2003-04-25 | 2005-03-31 | Medimmune Vaccines, Inc. | Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| JP2007525178A (ja) | 2003-04-25 | 2007-09-06 | メッドイミューン バクシーンズ，インコーポレイティド | メタニューモウイルス株、そのワクチン製剤における用途、抗原性配列の発現のためのベクターとしての用途、並びにウイルス増殖方法 |
| KR100999316B1 (ko) | 2003-06-09 | 2010-12-10 | 와이어쓰 엘엘씨 | ｃＤＮＡ로부터의 비분절 네가티브 쇄 ＲＮＡ 바이러스의회수를 위한 개선된 방법 |
| CN107818197B (zh) * | 2017-09-15 | 2021-05-25 | 南京航空航天大学 | 一种基于piv技术的超声速翼型的测力方法和装置 |
| GB201816873D0 (en) * | 2018-10-17 | 2018-11-28 | Imperial Innovations Ltd | Fusion protein |
| CN113322241B (zh) * | 2021-05-14 | 2023-06-13 | 金宇保灵生物药品有限公司 | 一种牛副流感病毒3型病毒株bpiv3-nm及其应用 |
| CN116676275B (zh) * | 2023-03-17 | 2024-06-07 | 北京赛尔富森生物科技有限公司 | A基因型嵌合腮腺炎病毒株和制备方法及用途 |
| TW202535439A (zh) | 2023-11-17 | 2025-09-16 | 美商賽諾菲巴斯德公司 | 海藻糖疫苗調配物 |
| CN118909958B (zh) * | 2024-07-25 | 2025-02-07 | 中国兽医药品监察所 | 一株牛副流感病毒3型np蛋白杂交瘤细胞株及单抗和在检测抗原中的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| GB9200117D0 (en) * | 1992-01-06 | 1992-02-26 | Connaught Lab | Production of recombinant chimeric proteins for vaccine use |
| ATE181112T1 (de) | 1995-08-09 | 1999-06-15 | Schweiz Serum & Impfinst | Dem genom von minussträngigen rna-viren entsprechende cdna und verfahren zur herstellung von infektiösen minussträngigen rna-viren |
| JPH11513372A (ja) * | 1995-09-22 | 1999-11-16 | コノート ラボラトリーズ リミテッド | パラインフルエンザウイルスの糖タンパクおよびワクチン |
| US5869036A (en) * | 1995-12-08 | 1999-02-09 | St. Louis University | Live attenuated vaccines based on CP45 HPIV-3 strain and method to ensure attenuation in such vaccine |
| EP2112220A3 (en) | 1996-07-15 | 2010-01-06 | The Government of the United States of America, as represented by The Department of Health and Human Services | Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
| BR9809456B1 (pt) * | 1997-05-23 | 2011-06-28 | molécula isolada de polinucleotìdeo, composição de célula ou isenta de célula, partìcula de piv infeciosa, atenuada e imunogênica, e, composição imunogênica. |
-
2000
- 2000-06-15 KR KR1020027000325A patent/KR100940776B1/ko not_active Expired - Fee Related
- 2000-06-15 CA CA002378661A patent/CA2378661A1/en not_active Abandoned
- 2000-06-15 CN CNA2008100985262A patent/CN101392239A/zh active Pending
- 2000-06-16 DE DE60040289T patent/DE60040289D1/de not_active Expired - Lifetime
- 2000-06-16 EP EP08164460A patent/EP2019141A3/en not_active Withdrawn
- 2000-06-16 BR BR0013190-3A patent/BR0013190A/pt not_active Application Discontinuation
- 2000-06-16 IL IL14716700A patent/IL147167A0/xx unknown
- 2000-06-16 MX MXPA01013302A patent/MXPA01013302A/es active IP Right Grant
- 2000-06-16 ES ES00941614T patent/ES2312347T3/es not_active Expired - Lifetime
- 2000-06-16 CN CNB008101205A patent/CN100402651C/zh not_active Expired - Fee Related
- 2000-06-16 JP JP2001509524A patent/JP4813711B2/ja not_active Expired - Fee Related
- 2000-06-16 AT AT00941614T patent/ATE408693T1/de not_active IP Right Cessation
- 2000-06-16 WO PCT/US2000/017066 patent/WO2001004320A1/en not_active Ceased
- 2000-06-16 EP EP08164459A patent/EP2019140A3/en not_active Withdrawn
- 2000-06-16 EP EP00941614A patent/EP1194564B1/en not_active Expired - Lifetime
-
2001
- 2001-12-18 IL IL147167A patent/IL147167A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2019141A2 (en) | 2009-01-28 |
| EP1194564B1 (en) | 2008-09-17 |
| BR0013190A (pt) | 2002-07-16 |
| EP1194564A1 (en) | 2002-04-10 |
| EP2019141A3 (en) | 2009-02-04 |
| KR20020022768A (ko) | 2002-03-27 |
| CA2378661A1 (en) | 2001-01-18 |
| DE60040289D1 (de) | 2008-10-30 |
| CN100402651C (zh) | 2008-07-16 |
| ES2312347T3 (es) | 2009-03-01 |
| EP2019140A2 (en) | 2009-01-28 |
| JP2003504064A (ja) | 2003-02-04 |
| ATE408693T1 (de) | 2008-10-15 |
| EP2019140A3 (en) | 2009-02-04 |
| WO2001004320A1 (en) | 2001-01-18 |
| JP4813711B2 (ja) | 2011-11-09 |
| IL147167A (en) | 2010-06-16 |
| IL147167A0 (en) | 2002-08-14 |
| KR100940776B1 (ko) | 2010-02-11 |
| CN101392239A (zh) | 2009-03-25 |
| CN1369011A (zh) | 2002-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA01013302A (es) | Vacunas para el virus de la parainfluenza (piv) quimerico para humanos-bovinos atenuadas. | |
| ATE419369T1 (de) | Chimäre mensch-rinder respiratory syncytial virus vakzinen | |
| WO2001042445A3 (en) | USE OF RECOMBINANT PARAINFLUENZA VIRUSES (PIVs) AS VECTORS TO PROTECT AGAINST INFECTION AND DISEASE CAUSED BY PIV AND OTHER HUMAN PATHOGENS | |
| Lu et al. | A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike | |
| ATE85622T1 (de) | Chimarenglykoproteine, enthaltend immunogene segmente des humanen respiratorischen synzytialvirus. | |
| DE69842165D1 (de) | Herstellung attenuierter parainfluenza-virus impfstoffe aus klonierten nukleotidsequenzen | |
| DE60139026D1 (de) | Lebender influenza impfstoff und verfahren zu seiner herstellung | |
| AU2013322635B2 (en) | Recombinant Measles virus expressing Chikungunya virus polypeptides and their applications | |
| CA2230033A1 (en) | Production of infectious respiratory syncytial virus from cloned nucleotide sequences | |
| HU229101B1 (en) | Dna transfection system for the generation of infectious influenza virus | |
| JP2014507146A5 (enExample) | ||
| WO2003043587A3 (en) | Recovery of recombinant human parainfluenza virus type 1 (hpiv1) from cdna | |
| Operschall et al. | Enhanced protection against viral infection by co-administration of plasmid DNA coding for viral antigen and cytokines in mice | |
| CN103160473B (zh) | 用于拯救麻疹病毒的组合物、试剂盒、用途及方法 | |
| KR890700030A (ko) | 인플루엔자균(Haemophilus influenzae)의 백신 및 진단방법 | |
| JP2000512263A (ja) | インフルエンザワクチン | |
| ATE307606T1 (de) | Abgeschwächter mutantenstamm eines virus der newcastle-krankheit für eine in ovo impfung und dessen benutzung | |
| WO2002002605A3 (en) | Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines | |
| DE60136811D1 (de) | Respiratorische synzytialvirus impfstoffe, welche schützende antigene von promotor-proximalen genen exprimieren | |
| Park et al. | Immune induction and modulation in mice following immunization with DNA encoding F protein of respiratory syncytial virus | |
| BR0105530A (pt) | Vìrus da parainfluenza, métodos para estimular o sistema imune de um paciente para induzir proteção contra o vìrus da parainfluenza e para produzir uma partìcula de vìrus da parainfluenza, método de imunização sequencial para estimular o sistema imune de um paciente a induzir proteção contra patógenos múltiplos, composição imunogênica para evocar uma resposta imune contra o virus da parainfluenza, polinucleotìdeo isolado e vetor de expressão | |
| TH62970A (th) | วัคซีนไวรัสโรคเบอร์ซาอักเสบติดต่อชนิดบรอดสเปคตรัม (broad spectrum) | |
| Truyen et al. | Studies on linear epitopes of Semliki Forest virus in protection studies against lethal challenge virus infection | |
| Knowles | A comparison of the pathogenesis of human adenovirus type 5 with that of a human adenovirus type 5 recombinant containing the rabies glycoprotein gene in mice. | |
| CA2519282A1 (en) | Development of a preventive vaccine for filovirus infection in primates |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |